Sarepta Therapeutics (Nasdaq: SRPT) is trading higher Tuesday amid a new U.S. patent being grated to the company.

According ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE